Skylight Health Group Inc.

Skylight Health Group Inc.

SLHG
Skylight Health Group Inc.US flagNASDAQ Capital Market
0.58
USD
-0.01
- -
Skylight Health Group Inc.
SLHG
(NASDAQ Capital Market)

Recent

price

0.58

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Skylight Health Group Inc is a healthcare services and technology company operating a multi-state primary care health network in the United States. It provides a comprehensive range of medical services including primary care; subspecialty care; allied health services; laboratory and diagnostic testing; and telemedicine services under a subscription-based model targeting uninsured and underinsured populations. The company’s proprietary electronic health record system supports virtual and physical care delivery. Founded in 2009 and headquartered in Toronto, Skylight Health focuses on value-based care models and contracts primarily with Medicare, Medicaid, and commercial payors. Recent strategic changes include the closure of loss-making Rocky Mountain Health Care clinics in Colorado to focus on operations in Florida, participation in the ACO Reach program transitioning to a capitated full-risk model aimed at enhancing funding and patient outcomes, and the rollout of the Athena electronic health record system to improve operational efficiency and revenue cycle management. Skylight also completed a $5 million convertible debenture financing to support ongoing growth initiatives, demonstrating a shift toward streamlining operations and expanding their value-based care footprint across the U.S. market.

Company News

APIChat
  • Skylight Health Group's (SLHG) CEO Pradyum Sekar on Q2 2022 Results - Earnings Call Transcript

  • Skylight Health Announces Timing of its Second Quarter 2022 Results Conference Call

  • Skylight Health Group Inc. (SLHG) CEO Pradyum Sekar on Q1 2022 Results - Earnings Call Transcript

  • Skylight Health Announces Earnings Call and Corporate Update

  • 3 Best Telemedicine Stocks for Investors

  • Skylight Health Group Inc. (SLHG) CEO Pradyum Sekar on Q4 2021 Results - Earnings Call Transcript

  • New Preferred Stock IPOs, December 2021

  • Skylight Health Group: Rapidly Growing National Primary Healthcare Platform

  • Skylight Health Group to Present at The Benchmark Company's Discovery One on One Virtual Video Investor Conference

  • Skylight Health Group, Inc.'s (SLHG) CEO Pradyum Sekar on Q3 2021 Results - Earnings Call Transcript

  • New Frontier Data To Buy Medical Cannabis Businesses Of Skylight Health Group For $8.63M In Cash

  • Skylight Health Bolsters Value-Based Care Capability as Industry Veteran Greg Sieman Joins Leadership Team

  • Skylight Health Group Enters New State Acquiring Pennsylvania Clinic Group Aspire Health Concepts

  • Skylight Health Appoints Mohammad Bataineh as President

  • Skylight Health Group, Inc. (SLHG) CEO Pradyum Sekar on Q2 2021 Results - Earnings Call Transcript

  • Skylight Health Announces Expansion of ClinEdge Partnership and Award for First Colorado Study

  • Skylight Health Announces Results of 2021 Annual General & Special Meeting of Shareholders